ATE452636T1 - 3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen - Google Patents

3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen

Info

Publication number: ATE452636T1
Authority: AT; Austria
Prior art keywords: corresponds; hydrogen; 4alkyl; alkyl; group
Prior art date: 2006-09-11

Application number

AT07803325T

Other languages

English (en)

Inventor

Fabio Romano Di

Fabrizio Micheli

Giovanna Tedesco

Silvia Terreni

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-09-11

Filing date

2007-09-07

Publication date

2010-01-15

2007-09-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE452636T1 publication Critical patent/ATE452636T1/de

Links

208000020401 Depressive disease Diseases 0.000 title 1
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 10
229910052739 hydrogen Inorganic materials 0.000 abstract 7
239000001257 hydrogen Substances 0.000 abstract 7
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 7
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 4
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 abstract 4
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 abstract 2
125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 2
125000004093 cyano group Chemical group *C#N 0.000 abstract 2
229960003638 dopamine Drugs 0.000 abstract 2
-1 haloC1-4alkyl Chemical group 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical group 0.000 abstract 2
125000001072 heteroaryl group Chemical group 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229960002748 norepinephrine Drugs 0.000 abstract 2
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 abstract 2
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
125000000623 heterocyclic group Chemical group 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
239000000543 intermediate Substances 0.000 abstract 1
125000002950 monocyclic group Chemical group 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
239000000651 prodrug Substances 0.000 abstract 1
229940002612 prodrug Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940076279 serotonin Drugs 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

AT07803325T 2006-09-11 2007-09-07 3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen ATE452636T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0617867.7A GB0617867D0 (en)	2006-09-11	2006-09-11	Chemical compounds
PCT/EP2007/059380 WO2008031771A2 (en)	2006-09-11	2007-09-07	3-azabicyclo [4. 1. 0] heptane derivatives for the treatment of depression

Publications (1)

Publication Number	Publication Date
ATE452636T1 true ATE452636T1 (de)	2010-01-15

Family

ID=37232741

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07803325T ATE452636T1 (de)	2006-09-11	2007-09-07	3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen

Country Status (8)

Country	Link
US (1)	US20090281135A1 (de)
EP (1)	EP2061461B1 (de)
JP (1)	JP2010502760A (de)
AT (1)	ATE452636T1 (de)
DE (1)	DE602007003997D1 (de)
ES (1)	ES2336047T3 (de)
GB (1)	GB0617867D0 (de)
WO (1)	WO2008031771A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0716573D0 (en) *	2007-08-24	2007-10-03	Glaxo Group Ltd	Chemical compounds
GB0804326D0 (en) *	2008-03-07	2008-04-16	Glaxo Group Ltd	Novel compounds
JP2013526507A (ja)	2010-05-12	2013-06-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、その製造方法及び薬物としてのその使用
CN104860870A (zh) *	2014-02-26	2015-08-26	欧美嘉股份有限公司	具有不同取代基的哌啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU651145B2 (en) *	1990-09-28	1994-07-14	Pfizer Inc.	Fused ring analogs of nitrogen containing nonaromatic heterocycles
US6635661B2 (en) *	2000-05-25	2003-10-21	Sepracor Inc.	Heterocyclic analgesic compounds and methods of use thereof

2006
- 2006-09-11 GB GBGB0617867.7A patent/GB0617867D0/en not_active Ceased
2007
- 2007-09-07 JP JP2009527792A patent/JP2010502760A/ja active Pending
- 2007-09-07 US US12/440,821 patent/US20090281135A1/en not_active Abandoned
- 2007-09-07 WO PCT/EP2007/059380 patent/WO2008031771A2/en not_active Ceased
- 2007-09-07 DE DE602007003997T patent/DE602007003997D1/de active Active
- 2007-09-07 ES ES07803325T patent/ES2336047T3/es active Active
- 2007-09-07 AT AT07803325T patent/ATE452636T1/de not_active IP Right Cessation
- 2007-09-07 EP EP07803325A patent/EP2061461B1/de active Active

Also Published As

Publication number	Publication date
ES2336047T3 (es)	2010-04-07
WO2008031771A3 (en)	2008-11-27
US20090281135A1 (en)	2009-11-12
WO2008031771A2 (en)	2008-03-20
JP2010502760A (ja)	2010-01-28
DE602007003997D1 (de)	2010-02-04
EP2061461B1 (de)	2009-12-23
GB0617867D0 (en)	2006-10-18
EP2061461A2 (de)	2009-05-27

Similar Documents

Publication	Publication Date	Title
EA201101566A1 (ru)	2012-05-30	Производные имидазола и их применение в качестве модуляторов циклинзависимых киназ
EA200701176A1 (ru)	2008-02-28	Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
PH12012502096B1 (en)	2018-03-07	Certain amino-pyrimidines, compositions thereof, and methods for their use
MX2017002241A (es)	2017-05-03	Compuestos de aminopirimidina como inhibidores de jak.
PH12017501192A1 (en)	2017-12-11	Certain amino-pyridazines, compositions thereof, and methods of their use
EA201001682A1 (ru)	2011-06-30	Производные фенил- и бензодиоксинилзамещенных индазолов
AR054560A1 (es)	2007-06-27	Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer
WO2008115098A3 (fr)	2008-11-13	2,3,4,5-tétrahydro-1h-pyrido[4,3-b]indoles substitués ainsi que procédés de leur fabrication et leur utilisation
EA200970461A1 (ru)	2009-12-30	ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
EA201001013A1 (ru)	2010-12-30	Бис(сульфониламино)производные для применения в терапии
AR088226A1 (es)	2014-05-21	Derivados piperidinicos heterociclicos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de enfermedades neurodegenerativas
EA200900135A1 (ru)	2009-06-30	Производные пиразола в качестве ингибиторов цитохрома р450
EA201201052A1 (ru)	2013-02-28	Замещенные нафтиридины и их применение в качестве ингибиторов киназы syk
BRPI0718966B8 (pt)	2021-05-25	composto, composição farmacêutica, inibidor plk1 e agente antitumoral
AR081426A1 (es)	2012-08-29	Derivados de pirazol inhibidores del receptor sigma
EA201390163A1 (ru)	2013-07-30	Гетеробициклические производные в качетстве ингибиторов hcv
ECSP099216A (es)	2010-03-31	Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
UY29312A1 (es)	2006-07-31	Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
AR062737A1 (es)	2008-11-26	Composicion farmaceutica que comprende un compuesto derivado de aril-azabiciclo, compuesto correspondiente y su uso para la preparacion de un medicamento
UY29393A1 (es)	2006-10-02	Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
PH12012500867A1 (en)	2014-10-14	Ethynyl derivatives
AR083832A1 (es)	2013-03-27	DERIVADOS DE TETRAHIDROPIRIDO[3,2-F][1,4]OXAZEPIN-8-AMINA PARA EL TRATAMIENTO DE ENFERMEDADES Ab-RELACIONADAS
ECSP088257A (es)	2008-04-28	Derivados de amida
DE602006019221D1 (de)	2011-02-10	Von dopamin-d3-rezeptoren
AR071619A1 (es)	2010-06-30	Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen.

Legal Events

Date	Code	Title	Description
2010-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties